Evidence map›Paper›PMID 38127105›Full record

ArticleInternational microbiology : the official journal of the Spanish Society for Microbiology2024

Molecular characterization of the multi-drug resistant Myroides odoratimimus isolates: a whole genome sequence-based study to confirm carbapenem resistance.

Esra Yartasi, Rıza Durmaz, Oguz Ari, Ipek Mumcuoglu, Bedia Dinc

Abstract read
PubMed Publisher
In one paragraph

Article in International microbiology : the official journal of the Spanish Society for Microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Genomic Diversity of theMicroorganisms · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Esra YartasiDepartment of Clinical Microbiology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Turkey.ORCID http://orcid.org/0000-0002-0434-1422
Rıza DurmazDepartment of Clinical Microbiology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey. rdurmaz@aybu.edu.tr.ORCID http://orcid.org/0000-0001-6561-778X
Oguz AriCentral Research and Application Center, Ankara Yildirim Beyazit University, Ankara, Turkey.ORCID http://orcid.org/0000-0003-4930-5035
Ipek MumcuogluDepartment of Clinical Microbiology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Turkey.ORCID http://orcid.org/0000-0002-6392-8880
Bedia DincDepartment of Clinical Microbiology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Turkey.ORCID http://orcid.org/0000-0001-8318-2556
Bilkent University · TRAnkara Yıldırım Beyazıt University · TR

Funding

Ankara Yıldırım Beyazıt University Research Foundation TSA-2021-2190
6 · The paper itself

Abstract

The bacteria belonging to the Myroides genus are opportunistic pathogens causing community or hospital-acquired infections that result in treatment failure due to antibiotic resistance. This study aimed to investigate molecular mechanisms of antibiotic resistance, clonal relatedness, and the biofilm forming capacity of the 51 multi-drug resistant Myroides odoratimimus. All isolates were screened for bla

Indexed as

Anti-Bacterial AgentsBiofilmsCarbapenemsDrug Resistance, Multiple, BacterialFlavobacteriaceaeGenome, BacterialWhole Genome Sequencingbeta-LactamasesElectrophoresis, Gel, Pulsed-FieldFlavobacteriaceae InfectionsHumansMicrobial Sensitivity TestsVirulence FactorsAnti-Bacterial Agentsbeta-LactamasesCarbapenemsVirulence FactorsBiofilmBla MUSDrug resistanceMyroides odoratimimusPFGE

Identifiers

PMID38127105
OpenAlexW4390062078

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.